[AOCNMB]

AOCNMB Symposium 1
Molecular imaging

Thu. Oct 5, 2017 3:30 PM - 5:00 PM Conference Room 2 (303+304, Conference Center 3F)

Chair: Satoshi Minoshima(Department of Radiology,The University of Utah, USA)

+Add all to schedule

[BS1-01] Imaging of Cell-Based Therapies

Noriko Sato (Molecular Imaging Program, National Cancer Institute, National Institutes of Health, USA)

[BS1-02] Development of PET probes and anti-cancer drugs targeting a cancer-specific amino acid transporter, LAT1

Shushi Nagamori (Bio-System Pharmacology, Department of Pharmacology, Osaka University)

[BS1-03] Novel PET probe to visualize AMPA receptors in living human brain

Takuya Takahashi (Department of Physiology, Yokohama City University)

[AOCNMB]

AOCNMB Symposium 2
Fukushima 2011 --- What we learned from the Nuclear Power Plant Accident ?

Fri. Oct 6, 2017 1:30 PM - 3:30 PM Conference Room 1 (Main Hall, Conference Center 1F)

Chair: Tatsuya Higashi(National Institute of Radiological Sciences), Kazuko Ohno(Kyoto College of Medial Science)

+Add all to schedule

[BS2-01] Impact of radiation emergencies on people - lessons learned from the Fukushima Daiichi Nuclear Power Plant Accident

Kenji Kamiya (Hiroshima University and Fukushima Medical University)

[BS2-02] Low Dose Radiation Effects on Fetus and Children

Yoshiya Shimada、Mayumi Nishimura、Shizuko Kakinuma (National Institutes for Quantum and Radiological Science and Technology)

[BS2-03] ¹³¹I Thyroid Dose Estimation from Food and Drink in the Early Phase after Fukushima Daiichi Nuclear Power Plant Accident

Masaki Kawai¹、Nobuaki Yoshizawa¹、Gen Suzuki² (1.Mitsubishi Research Institute, Inc.、2.International University of Health and Welfare Clinic)

[BS2-04] Estimation of thyroid equivalent dose at 1-year-old children by inhalation based on body surface contamination levels after the Fukushima Daiichi nuclear power plant accident

Takashi Ohba¹、Arifumi Hasegawa²、Gen Suzuki³ (1.Fukushima Medical University、2.Department of Radiation Disaster Medicine, Fukushima Medical University、3.International University of Health and Welfare Clinic)

[BS2-05] Special comment

Hisanori Fukunaga (Queen's University Belfast)

[AOCNMB]

AOCNMB Symposium 3
Global standardization and regulatory approval of imaging products, initiated by QIBA(Quantitative Imaging Biomarker Alliance) and the professional societies

Sat. Oct 7, 2017 8:00 AM - 10:00 AM Conference Room 2 (303+304, Conference Center 3F)

Chair: Ukihide Tateishi(Diagnostic Radiology and Nuclear Medicine,Tokyo Medical Dental University), Chieko Kurihara(National Institute of Radiological Sciences)

+Add all to schedule

[BS3-01] Global standardization and regulatory approval of imaging products, initiated by QIBA and the professional societies: introductory remarks

Chieko Kurihara (National Institute of Radiological Sciences)

[BS3-02] Quantitative Imaging Biomarker Alliance (QIBA): Overview and Emphasis on Nuclear Medicine Based Approaches

Richard L. Wahl (Washington University School of Medicine in St Louis, USA)

[BS3-03] PET drug manufacturing and imaging site qualification programs in Japan

Atsuo Waki (National Institute of Radiological Sciences)

[BS3-04] Activity of Quantitative Imaging Biomarkers Alliance (QIBA®) for Asian Network of FDG PET/CT Standardization

Ukihide Tateishi (Diagnostic Radiology and Nuclear Medicine, Tokyo Medical Dental University)

[AOCNMB]

AOCNMB Symposium 4
How to write scientific articles

Sat. Oct 7, 2017 10:00 AM - 12:00 PM Conference Room 2 (303+304, Conference Center 3F)

Chair: Seigo Kinuya(Department of Nuclear Medicine, Kanazawa University), S.Rasoul Zakavi(Mashhad University of Medical Science)

+Add all to schedule

[BS4-01] How to prepare an original article

Seyed Rasoul Zakavi (Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Iran)

[BS4-02] How to find an appropriate journal for submission

Ramin Sadeghi (Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Iran)

[BS4-03] Authorship and ethics

Seigo Kinuya (Department of Nuclear Medicine, Kanazawa University)

Sessions

AOCNMB Program » AOCNMB Symposia

AOCNMB Symposium 1
Molecular imaging

[BS1-01] Imaging of Cell-Based Therapies

[BS1-02] Development of PET probes and anti-cancer drugs targeting a cancer-specific amino acid transporter, LAT1

[BS1-03] Novel PET probe to visualize AMPA receptors in living human brain

AOCNMB Symposium 2
Fukushima 2011 --- What we learned from the Nuclear Power Plant Accident ?

[BS2-01] Impact of radiation emergencies on people - lessons learned from the Fukushima Daiichi Nuclear Power Plant Accident

[BS2-02] Low Dose Radiation Effects on Fetus and Children

[BS2-03] ¹³¹I Thyroid Dose Estimation from Food and Drink in the Early Phase after Fukushima Daiichi Nuclear Power Plant Accident

[BS2-04] Estimation of thyroid equivalent dose at 1-year-old children by inhalation based on body surface contamination levels after the Fukushima Daiichi nuclear power plant accident

[BS2-05] Special comment

AOCNMB Symposium 3
Global standardization and regulatory approval of imaging products, initiated by QIBA(Quantitative Imaging Biomarker Alliance) and the professional societies

[BS3-01] Global standardization and regulatory approval of imaging products, initiated by QIBA and the professional societies: introductory remarks

[BS3-02] Quantitative Imaging Biomarker Alliance (QIBA): Overview and Emphasis on Nuclear Medicine Based Approaches

[BS3-03] PET drug manufacturing and imaging site qualification programs in Japan

[BS3-04] Activity of Quantitative Imaging Biomarkers Alliance (QIBA®) for Asian Network of FDG PET/CT Standardization

AOCNMB Symposium 4
How to write scientific articles

[BS4-01] How to prepare an original article

[BS4-02] How to find an appropriate journal for submission

[BS4-03] Authorship and ethics

Authentication

Sessions

AOCNMB Program » AOCNMB Symposia

AOCNMB Symposium 1Molecular imaging

AOCNMB Symposium 2Fukushima 2011 --- What we learned from the Nuclear Power Plant Accident ?

AOCNMB Symposium 3Global standardization and regulatory approval of imaging products, initiated by QIBA(Quantitative Imaging Biomarker Alliance) and the professional societies

AOCNMB Symposium 4How to write scientific articles

Authentication

AOCNMB Symposium 1
Molecular imaging

AOCNMB Symposium 2
Fukushima 2011 --- What we learned from the Nuclear Power Plant Accident ?

AOCNMB Symposium 3
Global standardization and regulatory approval of imaging products, initiated by QIBA(Quantitative Imaging Biomarker Alliance) and the professional societies

AOCNMB Symposium 4
How to write scientific articles